Midas Letter Interview from Feb 6, 2019 re future takeout Chris Miller: Yeah, no, that’s always an issue; I mean, anytime you’re a CPG company like us, production is hard, and you know, it’s been fun to watch, I don’t know, the rumour mill, the talk, in the drink space about putting out CBD beverages. I think a lot of companies are going to struggle with production. One of the things that makes Koios Beverage Corp. unique is that we have our own production lines in Denver, that allow us to not only small-batch but innovate.
So a lot of guys have tried to come out with CBD products, they’re going to run into some issues in terms of how it’s made, shelf life, taste, that sort of thing. We have our own lines that can do up to 8,000 cases a day, and we have two of them. And so we’re fairly unique that way; it allows us to stay incredibly nimble. Instead of co-packing, you know, spending $2 million at a time to make product.
James West: Right.
Chris Miller: We don’t have to do that.
James West: Okay. So is it conceivable that this might be a future takeout for like a Pepsi or a –
Chris Miller: 100 percent.
James West: And is that what you’re kind of thinking, of building a lifestyle branded beverage line CBD-driven that would be of interest to a larger –
Chris Miller: Yeah, no, we, one of our Board of Directors members is the global Director of Molson Coors.
James West: Oh, okay.
Chris Miller: And so, it’s interesting: I meet with him once a week, I think it’s more therapy than anything.
James West: Okay.
Chris Miller: It’s more of a – yeah, because he’s in that space, and he understands it. But it’s interesting to know those guys that know how much beer is even struggling. Some of your listeners who know cannabis probably know that too –
James West: Yeah.